Characterizing the course of suicidal ideation response to ketamine

BACKGROUND: No pharmacological treatments exist for active suicidal ideation (SI), but the glutamatergic modulator ketamine elicits rapid changes in SI. We developed data-driven subgroups of SI trajectories after ketamine administration, then evaluated clinical, demographic, and neurobiological fact...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Affect Disord
Main Authors: Ballard, Elizabeth D., Yarrington, Julia S., Farmer, Cristan A., Richards, Erica, Machado-Vieira, Rodrigo, Kadriu, Bashkim, Niciu, Mark J., Yuan, Peixiong, Park, Lawrence, Zarate, Carlos A.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6193483/
https://ncbi.nlm.nih.gov/pubmed/30099268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2018.07.077
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares